Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Tackling cancer in China

NCID 2011

16 - 18 May 2011

Published: 26 May 2011

Views: 6290

Rating:

Save

Dr Ping Zhao - National Cancer Institute, China

Dr Ping Zhao, Director of the National Cancer Institute, China, talks to ecancer reporter Peter Goodwin about preventing and treating cancer in the world's most populous country.

Related Videos

Part 1: Why test?

Dr Elena Castro - Hospital Universitario 12 de Octubre, Madrid, Spain

Part 1: Why test? ( Dr Elena Castro - Hospital Universitario 12 de Octubre, Madrid, Spain )

Part 2: How to get biopsies for testing?

Dr Lynda Corrigan and Dr Stephen Finn

Part 2: How to get biopsies for testing? ( Dr Lynda Corrigan and Dr Stephen Finn )

Part 3: Managing testing efficiencies – How to optimise next generation sequencing and HRR testing

Prof Eva Compérat - Medical University of Vienna, Vienna, Austria

Part 3: Managing testing efficiencies – How to optimise next generation sequencing and HRR testing ( Prof Eva Compérat - Medical University of Vienna, Vienna, Austria )

MCED blood test demonstrates high specificity, strong predictive value, and increased early cancer detection

Dr Nima Nabavizadeh - Oregon Health & Science University, Portland, USA

MCED blood test demonstrates high specificity, strong predictive value, and increased early cancer detection ( Dr Nima Nabavizadeh - Oregon Health & Science University, Portland, USA )

Mobile prostate cancer screening clinic can help address barriers to serving high-risk communities

Dr Masood Moghul - The Royal Marsden Institute of Cancer Research, London, UK

Mobile prostate cancer screening clinic can help address barriers to serving high-risk communities ( Dr Masood Moghul - The Royal Marsden Institute of Cancer Research, London, UK )

Tele-mentoring: Impact of project ECHO

Dr Sanjeev Arora - Project ECHO, Albuquerque, USA

Tele-mentoring: Impact of project ECHO ( Dr Sanjeev Arora - Project ECHO, Albuquerque, USA )

ESMO 2024: Optimising the personalisation of prostate cancer treatment

Prof Alison Birtle, Dr Alejo Rodríguez-Vida, Dr Pasquale Rescigno and Prof Gunhild von Amsberg

ESMO 2024: Optimising the personalisation of prostate cancer treatment ( Prof Alison Birtle, Dr Alejo Rodríguez-Vida, Dr Pasquale Rescigno and Prof Gunhild von Amsberg )

ERBB2 amplifications across sex, race, and cancer types studied to guide HER2 therapies

Dr Marc Machaalani - Dana-Farber Cancer Institute, Boston, USA

ERBB2 amplifications across sex, race, and cancer types studied to guide HER2 therapies ( Dr Marc Machaalani - Dana-Farber Cancer Institute, Boston, USA )

Psychological issues in familial cancer

Dr Arnab Mukherjee - Tata Medical Center, Kolkata, India

Psychological issues in familial cancer ( Dr Arnab Mukherjee - Tata Medical Center, Kolkata, India )

More from ecancer